Genomics

Cell Technology's Natural Gene Repair Mechanisms

Published in Cancer Weekly, June 26th, 1995

Oncor, Inc., Gaithersburg, Maryland, and its majority-owned subsidiary, OncorPharm, Inc. announced its exclusive licensing of a U.S. patent application on DNA repair.

The patent is assigned to Yale University by the inventor Peter M. Glazer, M.D., Ph.D., Assistant Professor of Therapeutic Radiology at Yale University School of Medicine.

The patent application covers methods of repairing mutations in living cells, using triple-strand oligonucleotides linked to DNA-interacting drugs, such as alkylators, intercalators or strand-breakers. This patent has an effective filing date of June 25, 1993, and is considered to be fundamental to the development of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-06-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry